SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-077110
Filing Date
2024-03-26
Accepted
2024-03-26 08:02:03
Documents
3
Period of Report
2024-03-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d799876d6k.htm 6-K 9655
2 EX-99.1 d799876dex991.htm EX-99.1 11243
3 GRAPHIC g799876g0326054808442.jpg GRAPHIC 3946
  Complete submission text file 0001193125-24-077110.txt   27713
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 24780966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)